182 related articles for article (PubMed ID: 16185269)
1. Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease.
Goebel WS; Mark LA; Billings SD; Meyers JL; Pech N; Travers JB; Dinauer MC
J Invest Dermatol; 2005 Oct; 125(4):705-10. PubMed ID: 16185269
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease.
Petersen JE; Hiran TS; Goebel WS; Johnson C; Murphy RC; Azmi FH; Hood AF; Travers JB; Dinauer MC
J Invest Dermatol; 2002 Mar; 118(3):424-9. PubMed ID: 11874480
[TBL] [Abstract][Full Text] [Related]
3. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
[TBL] [Abstract][Full Text] [Related]
4. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
[TBL] [Abstract][Full Text] [Related]
5. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
Morgenstern DE; Gifford MA; Li LL; Doerschuk CM; Dinauer MC
J Exp Med; 1997 Jan; 185(2):207-18. PubMed ID: 9016870
[TBL] [Abstract][Full Text] [Related]
6. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease.
Dinauer MC; Gifford MA; Pech N; Li LL; Emshwiller P
Blood; 2001 Jun; 97(12):3738-45. PubMed ID: 11389011
[TBL] [Abstract][Full Text] [Related]
7. Stable long-term gene correction with low-dose radiation conditioning in murine X-linked chronic granulomatous disease.
Goebel WS; Pech NK; Dinauer MC
Blood Cells Mol Dis; 2004; 33(3):365-71. PubMed ID: 15528159
[TBL] [Abstract][Full Text] [Related]
8. Long-term high-level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and a Delta LNGFR cell surface marker.
Sadat MA; Pech N; Saulnier S; Leroy BA; Hossle JP; Grez M; Dinauer MC
Hum Gene Ther; 2003 May; 14(7):651-66. PubMed ID: 12804147
[TBL] [Abstract][Full Text] [Related]
9. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
[TBL] [Abstract][Full Text] [Related]
10. Retroviral-mediated gene transfer and nonmyeloablative conditioning: studies in a murine X-linked chronic granulomatous disease model.
Goebel WS; Dinauer MC
J Pediatr Hematol Oncol; 2002 Dec; 24(9):787-90. PubMed ID: 12468930
[TBL] [Abstract][Full Text] [Related]
11. Progress in gene therapy for chronic granulomatous disease.
Malech HL
J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
[TBL] [Abstract][Full Text] [Related]
12. High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox.
Ding C; Kume A; Björgvinsdóttir H; Hawley RG; Pech N; Dinauer MC
Blood; 1996 Sep; 88(5):1834-40. PubMed ID: 8781441
[TBL] [Abstract][Full Text] [Related]
13. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
[TBL] [Abstract][Full Text] [Related]
14. Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs.
Laugsch M; Rostovskaya M; Velychko S; Richter C; Zimmer A; Klink B; Schröck E; Haase M; Neumann K; Thieme S; Roesler J; Brenner S; Anastassiadis K
Mol Ther; 2016 Apr; 24(4):812-22. PubMed ID: 26316390
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for chronic granulomatous disease.
Kume A; Dinauer MC
J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.
Saulnier SO; Steinhoff D; Dinauer MC; Zufferey R; Trono D; Seger RA; Hossle JP
J Gene Med; 2000; 2(5):317-25. PubMed ID: 11045425
[TBL] [Abstract][Full Text] [Related]
17. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
18. Progress toward effective gene therapy for chronic granulomatous disease.
Malech HL; Choi U; Brenner S
Jpn J Infect Dis; 2004 Oct; 57(5):S27-8. PubMed ID: 15507764
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy of chronic granulomatous disease.
Grez M; Becker S; Saulnier S; Knöss H; Ott MG; Maurer A; Dinauer MC; Hoelzer D; Seger R; Hossle JP
Bone Marrow Transplant; 2000 May; 25 Suppl 2():S99-104. PubMed ID: 10933200
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for chronic granulomatous disease.
Goebel WS; Dinauer MC
Acta Haematol; 2003; 110(2-3):86-92. PubMed ID: 14583668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]